We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$69.4B
AUM Growth
-$5.97B
Cap. Flow
-$8.1B
Cap. Flow %
-11.68%
Top 10 Hldgs %
11.91%
Holding
4,468
New
541
Increased
1,601
Reduced
1,691
Closed
599

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$1.03B
2
UNH icon
UnitedHealth
UNH
+$686M
3
TSLA icon
Tesla
TSLA
+$387M
4
ABT icon
Abbott
ABT
+$380M
5
CVX icon
Chevron
CVX
+$328M

Sector Composition

Rank Sector Weight
1 Technology 20.26%
2 Healthcare 16.96%
3 Consumer Discretionary 12.82%
4 Consumer Staples 9.14%
5 Industrials 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATNX
4451
DELISTED
Athenex, Inc. Common Stock
ATNX
-58,759
Closed -$78K
LCI
4452
DELISTED
Lannett Company, Inc.
LCI
-482,544
Closed -$840K
TMBR
4453
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
-17,700
Closed -$30K
XELA
4454
DELISTED
Exela Technologies, Inc. Common Stock
XELA
-23,669
Closed -$184K
SRGA
4455
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
-53,414
Closed -$85K
PTE
4456
DELISTED
PolarityTE, Inc. Common Stock
PTE
-75,622
Closed -$38K
VISL
4457
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
-960
Closed -$7K
NAVB
4458
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
-238,133
Closed -$62K
CO
4459
DELISTED
Global Cord Blood Corporation
CO
-2,348,549
Closed -$702K
DISH
4460
DELISTED
DISH Network Corp.
DISH
-2,173,158
Closed -$20.3M
ATIP
4461
DELISTED
ATI Physical Therapy, Inc.
ATIP
-6,308
Closed -$80K
VSTO
4462
DELISTED
Vista Outdoor Inc.
VSTO
-247,400
Closed -$6.86M
EBIX
4463
DELISTED
Ebix Inc
EBIX
-154,489
Closed -$2.04M
YELL
4464
DELISTED
Yellow Corporation Common Stock
YELL
-296,690
Closed -$602K
CEMI
4465
DELISTED
Chembio diagnostics, Inc.
CEMI
-157,100
Closed -$69K
IMH
4466
DELISTED
Impac Mortgage Holdings Inc.
IMH
-87,871
Closed -$31K
HHR
4467
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
-92,100
Closed -$138K
FIEE
4468
FiEE Inc
FIEE
$32.4M
-1,248
Closed -$3K

Similar funds

Jim Simons's Q2 2023 Portfolio in Review

As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.

  • Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
  • Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
  • Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
  • Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
  • Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
  • Jim Simons opened 541 new positions and closed 599 in Q2 2023.
  • Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.

Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.